Effect of L-theanine on depressive symptoms
Phase 2
Completed
- Conditions
- mood disorder
- Registration Number
- JPRN-UMIN000014653
- Lead Sponsor
- The ethics committee of the National Center of Neurology and Psychiatry
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
Participants were excluded if they had a prior medical history of central nervous system disease or severe head injury, or if they met the criteria for substance abuse or dependence. 20
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the molecular mechanisms by which L-theanine modulates mood disorders in phase II clinical trials?
How does L-theanine compare to SSRIs in treating depressive symptoms in mood disorder patients?
What biomarkers are associated with response to L-theanine in phase II trials for mood disorders?
What adverse events are reported in L-theanine trials for mood disorders and how are they managed?
Are there combination therapies involving L-theanine and standard antidepressants for mood disorders?